DF 7.5 (Enablex 7.5 mg)
Generic Name: darifenacin
Pill imprint DF 7.5 has been identified as Enablex 7.5 mg.
Enablex is used in the treatment of urinary incontinence; overactive bladder and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Enablex 7.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for DF 7.5 (Enablex 7.5 mg)
- Generic Name:
- darifenacin
- Imprint:
-
DF
7.5 - Strength:
- 7.5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Urinary antispasmodics
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0419
- Inactive Ingredients:
- calcium phosphate dibasic anhydrous
hypromelloses
polyethylene glycol
magnesium stearate
titanium dioxide
magnesium silicate
| NDC Code | Manufacturer / Repackager |
|---|---|
| 35356-0273 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
More resources
Enablex is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

